Registrar Corp. Expands Global Compliance Reach with Acquisition of CMC Medical Devices

NoahAI News ·
Registrar Corp. Expands Global Compliance Reach with Acquisition of CMC Medical Devices

Registrar Corp., a U.S.-based compliance specialist and unit of Paine Schwartz Partners, has acquired Spanish medical device consulting services provider CMC Medical Devices. This strategic move significantly broadens Registrar's global footprint in the medical device regulatory compliance sector.

Expanded Market Access and Service Offerings

The acquisition is set to enhance Registrar's ability to serve medical device and in vitro diagnostic regulation companies, with a particular focus on assisting them in bringing new products to market. By combining forces with CMC Medical, Registrar Corp. anticipates reaching over 75% of the global medical device market.

Raj Shah, CEO of Registrar Corp., emphasized the strategic importance of the acquisition, stating, "Together, we offer medical device manufacturers a single partner to navigate complex regulations and access the U.S., EU, and other key global markets—so they can focus on innovation rather than compliance."

Global Reach and Client Base

CMC Medical Devices brings to the table an impressive client base spanning more than 70 countries. This extensive network complements Registrar Corp.'s existing presence across 190 countries, where it provides consulting services not only in medical devices but also in food and beverage, cosmetics, and over-the-counter drugs.

Manuel Mateos, CEO of CMC Medical, expressed enthusiasm about the merger: "Joining Registrar Corp. enables us to deliver even greater value to our clients. Our shared mission is to help manufacturers reach patients faster with trusted, region-specific compliance support."

Industry Trend Towards Consolidation and Rapid Testing

This acquisition aligns with a broader industry trend towards consolidation and enhanced testing capabilities. Just a week prior, Swiss CDMO Lonza acquired French rapid microbiology testing firm Redberry SAS for an undisclosed sum. Lonza's move was driven by the pharmaceutical industry's growing demand for faster product releases without compromising safety or regulatory standards.

While financial details of Registrar's acquisition of CMC Medical were not disclosed, the deal underscores the increasing importance of comprehensive global compliance services in the medical device and pharmaceutical sectors.

References